| N4-(9-Ethyl-9H-carbazol-3-yl)-N2-(3-Morpholin-4-yl-propyl)-pyriMidine-2,4-diaMine |
EHOP-016;N4-(9-ETHYL-9H-CARBAZOL-3-YL)-N2-(3-MORPHOLIN-4-YL-PROPYL)-PYRIMIDINE-2,4-DIAMINE |
1380432-32-5 |
| TRIPELENNAMINE HYDROCHLORIDE |
盐酸曲吡那敏 |
154-69-8 |
| P 22077 |
P 22077 |
1247819-59-5 |
| B-HT 920 DIHYDROCHLORIDE |
盐酸他利克索 |
36085-73-1 |
| SL 327 |
SL 327 |
305350-87-2 |
| ML234 |
ML324 |
1222800-79-4 |
| 5-((7-Cl-1H-indol-3-yl)Methyl)-3-MethyliMidazolidine-2,4-dione) |
5-[(7-氯-1H-吲哚-3-基)甲基]-3-甲基-2,4-咪唑烷二酮 |
852391-15-2 |
| Histone Acetyltransferase Inhibitor IV, CPTH2 |
CPTH2 |
357649-93-5 |
| Saxagliptin |
沙格列汀 |
361442-04-8 |
| CP21R7(CP21) |
GSK-3Β抑制剂(CP21R7) |
125314-13-8 |
| Irsogladine |
伊索拉定 |
57381-26-7 |
| b-AP15 |
b-AP15 |
1009817-63-3 |
| Cabozantinib |
卡博替尼 |
849217-68-1 |
| Fexinidazole |
非昔硝唑 |
59729-37-2 |
| Ruxolitinib |
鲁索利替尼 |
941678-49-5 |
| Lonidamine |
氯尼达明 |
50264-69-2 |
| LDAO |
月桂基二甲基氧化胺 |
1643-20-5 |
| CGP 57380 |
N3-(4-氟苯基)-1H-吡唑并[3,4-D]嘧啶-3,4-二胺 |
522629-08-9 |
| 4-BroMo-N-(4-broMophenyl)-3-[[(phenylMethyl)aMino]sulfonyl]benzaMide |
4-溴-N-(4-溴苯基)-3-[[(苯基甲基)氨基]磺酰基]苯甲酰胺 |
312756-74-4 |
| PYR 41 |
PYR 41 |
418805-02-4 |
